盐酸环丙沙星，CAS 登记号 93107-08-5，由济南圣和化工有限公司现货供应，可提供纯度 按批次COA提供(不公开发布) 的规格，下游主要用于医药中间体及原料药。支持样品与小批量试用，批量价格请联系我们获取，验收以批次 COA 为准。
医药中间体及原料药
每批随货提供 COA；可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号，一个工作日内回复报价。
本页已列出 盐酸环丙沙星 的 CAS 号：93107-08-5，可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布)，包装形式为 按订单/批次确认(不公开发布)，特殊规格可在询价时说明。
主要涉及医药中间体及原料药。
来信 info@591daili.com 或 WhatsApp 联系，提供产品名称、CAS 号与数量，确认价格与交期后即可安排发货，验收以批次 COA 为准。
Ciprofloxacin Monohydrochloride · CAS 93107-08-5 · C17H19ClFN3O3. UNII 0MP32MFP6C.
| CAS Registry Number | 93107-08-5 |
|---|---|
| PubChem CID | 62999 |
| Molecular formula | C17H19ClFN3O3 |
| IUPAC name | 1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid;hydrochloride |
| UNII (FDA) | 0MP32MFP6C |
| Molecular Weight | 367.8 |
|---|---|
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 3 |
| Exact Mass | 367.1098973 |
| Monoisotopic Mass | 367.1098973 |
| Topological Polar Surface Area | 72.9 |
| Heavy Atom Count | 25 |
| Formal Charge | 0 |
| Complexity | 571 |
| Reported hazard statements | H315 (33.3%), H317 (66.7%), H319 (66.7%), H334 (66.7%), H335 (33.3%), H400 (33.3%), H410 (66.7%) |
|---|
H315 (33.3%): Causes skin irritation [Warning Skin corrosion/irritation]
H317 (66.7%): May cause an allergic skin reaction [Warning Sensitization, Skin]
93107-08-5; Ciprofloxacin Hydrochloride Anhydrous; 0MP32MFP6C; RefChem:918672; 86483-48-9; 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride; 1-Cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid xhydrochloride; 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid hydrochloride; Ciprofloxacin monohydrochloride; CHEBI:310388; Bay o 9867; Ciprofloxacin (monohydrochloride); BAY-O-9867; Ciproxan; Ciproxin; ciprofloxacin hydrochloride (anhydrous)
CAS 93107-08-5; molecular formula C17H19ClFN3O3; molecular weight — g/mol.
93107-08-5, Ciprofloxacin Hydrochloride Anhydrous, 0MP32MFP6C, RefChem:918672, 86483-48-9, 1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride.
Hazard statements reported: H315, H317, H319, H334, H335.
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.